1. Clinical Overview
Eberconazole is a modern, broad-spectrum imidazole antifungal agent used topically for the treatment of superficial fungal infections. It is characterized by its potent fungistatic and fungicidal activity against dermatophytes, yeasts (including Candida spp.), and molds. It exhibits high lipophilicity, promoting deep penetration into the stratum corneum and creating a reservoir effect for prolonged action. In the Indian context, it is a widely prescribed first-line treatment for dermatophytosis (tinea infections) due to its efficacy and favorable safety profile.
| Onset | Duration | Bioavailability |
|---|---|---|
| Clinical improvement is typically observed within 3-5 days of initiation of therapy. | The reservoir effect in the skin can provide antifungal activity for up to 48-72 hours after the last application. | Negligible systemic absorption (<1% of the applied dose) following topical administration on intact skin. |
2. Mechanism of Action
Eberconazole inhibits the synthesis of ergosterol, an essential component of the fungal cell membrane. It acts by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase. This inhibition leads to the accumulation of toxic methylated sterol precursors (e.g., 14-α-methyl sterols) and depletion of ergosterol, compromising membrane integrity and function.
3. Indications & Uses
- Tinea corporis (ringworm of the body)
- Tinea cruris (jock itch)
- Tinea pedis (athlete's foot)
- Cutaneous candidiasis
- Pityriasis versicolor (caused by Malassezia furfur)
4. Dosage & Administration
Adult Dosage: Apply a thin layer to cover the affected and surrounding area once or twice daily, as directed by the physician. Typical duration is 2-4 weeks.
Administration: Wash and dry the affected area thoroughly before application. Apply with clean hands. For intertriginous areas (e.g., groin, under breasts), the powder or lotion formulation may be preferred. Continue use for the full prescribed duration, even if symptoms improve earlier, to prevent recurrence.
5. Side Effects
Common side effects may include:
- Mild, transient burning or stinging at the application site
- Localized erythema (redness)
- Itching (pruritus)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Topical Medications (e.g., corticosteroids, retinoids) | Potential for increased local irritation. Apply at different times if multiple topicals are prescribed. | Moderate |
| Systemically administered Azole Antifungals (e.g., Ketoconazole, Fluconazole) | Theoretical risk of additive effects, but clinically insignificant due to negligible systemic absorption of topical Eberconazole. | Low |
7. Patient Counselling
- DO wash hands before and after application.
- DO clean and dry the affected area thoroughly before applying.
- DO wear loose, cotton clothing over treated areas to reduce moisture and friction.
- DON'T apply to eyes, nose, mouth, or inside the vagina.
- DON'T use occlusive dressings (bandages, wraps) unless directed by the doctor.
- DON'T share towels, clothing, or bedding to prevent spreading the infection.
8. Toxicology & Storage
Overdose: Acute topical overdose is unlikely to cause systemic symptoms due to poor absorption. Symptoms would be limited to severe local skin irritation, burning, erythema, or contact dermatitis.
Storage: Store at room temperature (below 30°C). Protect from light and moisture. Keep the tube/container tightly closed. Keep out of reach of children. Do not freeze.